Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Gilbert was lead author on a set of clinical guidelines from the American College of Cardiology in 2025 that recommend providers consider GLP-1s as a first-line treatment option for weight management in patients with obesity to reduce cardiovascular risk
b , Cumulative food intake
Dietary fiber
InjectCos weight loss program includes ongoing support and progress tracking, with continued access to the care team between check-ins to help you stay engaged throughout the program
Sorensen G, Jensen M, Weikop P, Dencker D, Christiansen SH, Loland CJ et al
Semaglutide (Wegovy) typically follows this schedule: Weeks 1-4: 0.25 mg Weeks 5-8: 0.5 mg Weeks 9-12: 1.0 mg Weeks 13-16: 1.7 mg Week 17+: 2.4 mg (maintenance) Tirzepatide (Zepbound) uses a similar approach: Weeks 1-4: 2.5 mg Weeks 5-8: 5 mg Weeks 9-12: 7.5 mg Weeks 13-16: 10 mg Week 17+: 12.5 mg or 15 mg (if tolerated) Do not self-adjust doses
US$ 24.04
US$ 24.70
US$ 20.67
US$ 27.85
